Opioid Prescribing Guidelines

After studying other state and national recommendations, the Opioid Prescribing Guidelines for Oklahoma Workgroup created guidelines for Oklahoma prescribers in 2017. The guidelines were developed to help improve communication between clinicians and patients about the risks and benefits of opioid therapy for pain management, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder, overdose, and death, while preserving patient access to needed medical treatment.

In 2018, the Opioid Prescribing Guidelines for Oklahoma Workgroup partnered with the Oklahoma Perinatal Quality Improvement Collaborative’s (OPQIC) Oklahoma Mothers and Newborns affected by Opioids (OMNO) Project to form a multidisciplinary sub-workgroup called the Opioid Prescribing and Pregnancy Workgroup. This sub-workgroup aims to address the use of opioids for pain management in pregnant patients and the treatment of pregnant patients with opioid use disorder to improve patient outcomes. For more information and resources, visit http://opqic.org/omno.

• Opioid Prescribing Guidelines
• Risks of Opioids in Pregnancy: What You Need to Know
• Treating Pregnant Patients with Opioid Use Disorder

• Stigma: Why Words Matter
• Pocket Guide: Tapering
• Nonopioid Treatments
• Assessing Benefits and Harms of Opioid Therapy
• Calculating Total Daily Dose of Opioids for Safer Dosage
• Clinical Reminders for Prescribing Opioids
• Opioid Best Practices (SB1446)
• Sample Written Opioid Policy
• Sample Patient-Provider Agreement
• SBIRT (Screening, Brief Intervention, and Referral to Treatment) Fact Sheet
  
• SBIRT (Screening, Brief Intervention, and Referral to Treatment) Pocket Guide
  
• Project ECHO: A Telehealth Model for Rural Health Care
  
• MAT (Medication-assisted treatment) - Providers Clinical Support System

• Opioid Fact Sheet for Patients
• Pregnancy and Opioid Pain Medications Fact Sheet for Patients
• Pregnancy and Medication-Assisted Treatment (MAT) Fact Sheet for Patients
• Neonatal Abstinence Syndrome (NAS) Rack Card for Patient (English) or (Español)
• Naloxone - A Guide for Overdose Prevention

Mailing Address:
Oklahoma State Department of Health
Injury Prevention Service
123 Robert S. Kerr Ave., Suite 1702
Oklahoma City, OK 73102-6406

Physical Address:
Oklahoma State Department of Health
Injury Prevention Service
123 Robert S. Kerr Ave.
Oklahoma City, OK

Telephone: (405) 426-8440
Fax: (405) 900-7588
Email: injury@health.ok.gov